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From the Home to the Hospital: The New Bath Salts
Jeanne Zukas, DO; Matthew Cook, DO
Lehigh Valley Health Network, Allentown, Pennsylvania

Case

How Are They Used?

A 19-year-old woman nasally insufflated “bath salts” purchased at a
local truck stop. She presented to an emergency department 12 hours
later with persistent headache, palpitations, anxiety and insomnia. Vital
signs revealed blood pressure 152/94 mm Hg, heart rate 131 beats per
minute, and temperature 100.5 degrees Fahrenheit. EKG revealed sinus
tachycardia with QRS 82ms and QTc 464ms. The patient was treated
with intravenous lorazepam and observed. Her symptoms and vital signs
improved and she was discharged home with family. Subsequent GC/
MS (gas chromatography mass spectrometry) analysis of the “bath salts”
specimen provided by the patient indicated the presence of pyrovalerone.

•	Imported primarily from Europe
•	Sold as a powder in head shops, truck stops, convenience stores,
1
or online as “bath salts” .
1,2
• They are taken orally, intravenously, insufflated or by inhalation .

Diagnosis
•	Diagnosis is usually made by history given by patient or others.
•	If use suspected but not given in history, look for drug effects
which most strongly involve the neurologic, cardiovascular, and
3
psychiatric systems .

Side Effects
What are Bath Salts?
The designer drug bath salts are phenylethylamine compounds analogous
to other amphetamines; they include methylenedioxypyrovalerone (MDPV)
and 4-methylmethcathinone (mephedrone).
See chemical structures below and how closely they resemble
amphetamine structures.

•	Neurologic: sympathomimetic toxic syndrome, dizziness,
3
seizures, decreased motor control .
•	Cardiovascular: “tachycardia, hypertension, vasoconstriction,
4
and sweating” .
•	Psychiatric: intense drug craving, anxiety, psychosis, agitation,
insomnia, paranoia, suicidal ideation, changes in perception of
1
reality, and reduced ability to think clearly .
•	Complications: rhabdomyolysis, renal failure, liver failure, and
3
death .

Treatment
MDMA

(Ecstasy)

Methylmethcathinone
(Mephedrone)

MDPV

Methamphetamine
(C10H15N)

Treatment is similar to that of other stimulant drugs. Vital signs should be
monitored for hypertension, hyperthermia, or arrhythmias while laboratory
5
screening includes creatine kinase levels . Benzodiazepines have
been used for treatment of violent behavior, seizure, hypertension and
5
hyperthermia . Avoidance of beta blockers is suggested to avoid rebound
5
hypertensive urgency from alpha-adrenergic unopposition . Refractory
symptom management may require use of an antipsychotic such as
3
haloperidol or ziprasidone .

Summary
The above presentation is relatively mild compared to more severe
reactions that have been seen since the drug emerged in the United
States. The above case was an early presentation of what would
become a growing concern in the healthcare community.
An epidemic of “bath salts” abuse is novel in the U.S., with the drugs
marketed “not for human consumption” to circumvent the legal statutes
of the Federal Analog Act. Both drugs were initially unscheduled
6
“drugs of concern” according to the U.S Drug Enforcement Agency .
As of September 2011 bath salts are classified as illegal through an
emergency scheduling policy for one year until the DEA makes a
6
permanent scheduling decision . Bath salt usage among our patients is
a diagnosis of suspicion or by patient reporting its abuse. Most cases
do not have GC/MS analysis as confirmation. Awareness of the drug
and its effects is needed to guide its correct diagnosis and treatment.
More research in needed to fully elucidate the details of this substance.
Resources:
1.	Bath Salts or Designer Cathinones. XII. Drugs of Concern. Drugs of Abuse. 2011 Edition. A DEA
Resource Guide.
2.	Psychonaut Web Mapping Research Group (2009). MDPV Report. Institute of Psychiatry, King’s
College London: London UK.
3.	Emergency Department Visits After Use of a Drug Sold as “Bath Salts” – Michigan, November 13, 2010
March 31, 2011. Morbidity and Mortality Weekly Reporter. Vol 60 No. 19. May, 2011.
4.	Methylenedioxypyrovalerone (MDPV). Drug and Chemical Evaluation Section. Drug Enforcement
Administration. Office of Diversion Control. March 2011.
5.	“Bath Salts” Health Care Provider Fact Sheet. Michigan Department of Community Health. www.
michigan.gov/ documents/mdch/Bath_Salts_FAQ_Health_Care_Providers_344881_7.pdf
6.	Lowry, Fran. DEA Moves to Make “Bath Salts” Illegal as Overdoses Rise. Medscape Medical News.
www.Medscape.com
Chemical structures: Erowid. Erowid.org

